Search Media Items

Approximately 250 scientific stakeholders and leaders from academia, government, industry, and advocacy will gather in Washington, DC, July 29–31 for the NCI Childhood Cancer Data Initiative (CCDI) Symposium.

Immunotherapy, particularly immune checkpoint inhibitor therapy, can trigger an immune response that causes inflammation to organs. Organ-related side effects are listed to help you talk with your doctor and know when to seek urgent medical care.

Immunotherapy, including CAR-T cell therapy, and chemotherapy may cause flu-like side effects such as chills, diarrhea, fatigue, and fever. Some people may experience cytokine release syndrome (CRS). Learn what questions to ask your doctor and when to seek urgent medical care.

The research will create in vitro models of the fallopian-ovarian interaction within a normal ovulation context to examine key aspects of the ovarian microenvironment during tumor initiation and progression.

This page highlights recent research in the treatment of melanoma and other skin cancers, including targeted therapies, immune checkpoint inhibitors, and adoptive cell transfer. Selected NCI-supported programs to address these cancers are also described.

The Childhood Cancer Data Initiative focuses on the critical need to collect, analyze, and share data to address childhood cancer.

Learn more about NCI CGH Project ECHO® Program.

An overview of recent research results and progress related to diagnosing and treating prostate cancer, plus ongoing projects supported by NCI to further decipher the causes of prostate cancer and most effective ways to prevent, detect, and treat it.

An overview of recent research results and progress related to the prevention, early detection, and treatment of colorectal cancer, plus ongoing projects supported by NCI to further decipher the causes of colorectal cancer and most effective ways to treat it.

NCI-CONNECT hosts meetings at NIH throughout the year to bring together worldwide leaders in neuro-oncology to advance knowledge and collaborations.